|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 10 (November 15), 1999:
pp. 3349-3357
Improved Expression in Hematopoietic and Lymphoid Cells in Mice After
Transplantation of Bone Marrow Transduced With a Modified Retroviral
Vector
Stephanie Halene,
Lijun Wang,
Robert M. Cooper,
David C. Bockstoce,
Paul B. Robbins, and
Donald B. Kohn
From the Division of Research Immunology/Bone Marrow Transplantation,
Childrens Hospital Los Angeles, Los Angeles, CA; and the Department of
Pediatrics and Microbiology, University of Southern California School
of Medicine, Los Angeles, CA.
Retroviral vectors based on the Moloney murine leukemia virus
(MoMuLV) are currently the most commonly used vehicles for stable gene
transfer into mammalian hematopoietic cells. But, even with reasonable
transduction efficiency, expression only occurs in a low percentage of
transduced cells and decreases to undetectable levels over time. We
have previously reported the modified MND LTR
(myeloproliferative sarcoma virus enhancer,
negative control region deleted, dl587rev
primer-binding site substituted) to show increased expression frequency
and decreased methylation in transduced murine embryonic stem cells and
hematopoietic stem cells. We have now compared expression of the
enhanced green fluorescent protein (eGFP) from a vector using the
MoMuLV LTR (LeGFPSN) with that from the modified vector (MNDeGFPSN) in
mature hematopoietic and lymphoid cells in the mouse bone marrow
transplant (BMT) model. In primary BMT recipients, we observed a higher
frequency of expression from the MND LTR (20% to 80%) in
hematopoietic cells of all lineages in spleen, bone marrow, thymus, and
blood compared with expression from the MoMuLV LTR (5% to 10%).
Expression from the MND LTR reached 88% in thymic T lymphocytes and
54% in splenic B lymphocytes for up to 8 months after BMT. The mean
fluorescence intensity of the individual cells, indicating the amount
of protein synthesized, was 6- to 10-fold higher in cells expressing
MNDeGFPSN compared with cells expressing LeGFPSN. Transduction
efficiencies determined by DNA polymerase chain reaction of vector copy
number were comparable for the 2 vectors. Therefore, the MND vector
offers an improved vehicle for reliable gene expression in
hematopoietic cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H. Wang, J. Sun, and H. Goldstein
Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide
J. Virol.,
August 1, 2008;
82(15):
7591 - 7600.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Gao, M. A. Lobritz, J. Roth, M. Abreha, K. N. Nelson, I. Nankya, D. M. Moore-Dudley, A. Abraha, S. L. Gerson, and E. J. Arts
Targets of Small Interfering RNA Restriction during Human Immunodeficiency Virus Type 1 Replication
J. Virol.,
March 15, 2008;
82(6):
2938 - 2951.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. de la Grange, F. Armstrong, V. Duval, M.-C. Rouyez, N. Goardon, P.-H. Romeo, and F. Pflumio
Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells
Blood,
November 1, 2006;
108(9):
2998 - 3004.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Parikh, R. Subrahmanyam, and R. Ren
Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Blood,
October 1, 2006;
108(7):
2349 - 2357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Liu, J. Daviau, C. N. Nichols, and D. S. Strayer
In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors
Blood,
October 15, 2005;
106(8):
2655 - 2662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Kikuchi, S. Menendez, M. Ohori, C. Cordon-Cardo, N. Kasahara, and B. H. Bochner
Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin
Clin. Cancer Res.,
March 1, 2004;
10(5):
1835 - 1842.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kurre, J. Morris, B. Thomasson, D. B. Kohn, and H.-P. Kiem
Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells
Blood,
November 1, 2003;
102(9):
3117 - 3119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Haas, C. Lutzko, A. C. Logan, G. J. Cho, D. Skelton, X. Jin Yu, K. A. Pepper, and D. B. Kohn
The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells
J. Virol.,
September 1, 2003;
77(17):
9439 - 9450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Goto, B. Yang, D. Petersen, K. A. Pepper, P. A. Alfaro, D. B. Kohn, and C. P. Reynolds
Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines
Mol. Cancer Ther.,
September 1, 2003;
2(9):
911 - 917.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. McCauslin, J. Wine, L. Cheng, K. D. Klarmann, F. Candotti, P. A. Clausen, S. E. Spence, and J. R. Keller
In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals
Blood,
August 1, 2003;
102(3):
843 - 848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, S. Ge, G. McNamara, Q.-L. Hao, G. M. Crooks, and J. A. Nolta
Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells
Blood,
May 15, 2003;
101(10):
4201 - 4208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Baum, J. Dullmann, Z. Li, B. Fehse, J. Meyer, D. A. Williams, and C. von Kalle
Side effects of retroviral gene transfer into hematopoietic stem cells
Blood,
March 15, 2003;
101(6):
2099 - 2113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Edinger, Y.-A. Cao, M. R. Verneris, M. H. Bachmann, C. H. Contag, and R. S. Negrin
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
Blood,
January 15, 2003;
101(2):
640 - 648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Grove, C. Lutzko, J. Priller, O. Henegariu, N. D. Theise, D. B. Kohn, and D. S. Krause
Marrow-Derived Cells as Vehicles for Delivery of Gene Therapy to Pulmonary Epithelium
Am. J. Respir. Cell Mol. Biol.,
December 1, 2002;
27(6):
645 - 651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Horn, M. S. Topp, J. C. Morris, S. R. Riddell, and H.-P. Kiem
Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells
Blood,
December 1, 2002;
100(12):
3960 - 3967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Brown and D. Lillicrap
Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy
Blood,
July 30, 2002;
100(4):
1133 - 1140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wahlers, P. F. Zipfel, M. Schwieger, W. Ostertag, and C. Baum
In Vivo Analysis of Retroviral Enhancer Mutations in Hematopoietic Cells: SP1/EGR1 and ETS/GATA Motifs Contribute to Long Terminal Repeat Specificity
J. Virol.,
January 1, 2002;
76(1):
303 - 312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Vassilopoulos, G. Trobridge, N. C. Josephson, and D. W. Russell
Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors
Blood,
August 1, 2001;
98(3):
604 - 609.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Crooks, Q.-L. Hao, D. Petersen, L. W. Barsky, and D. Bockstoce
IL-3 Increases Production of B Lymphoid Progenitors from Human CD34+CD38- Cells
J. Immunol.,
September 1, 2000;
165(5):
2382 - 2389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chinnasamy, N. Chinnasamy, M. J. Enriquez, M. Otsu, R. A. Morgan, and F. Candotti
Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins
Blood,
August 15, 2000;
96(4):
1309 - 1316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Emery, E. Yannaki, J. Tubb, and G. Stamatoyannopoulos
A chromatin insulator protects retrovirus vectors from chromosomal position effects
PNAS,
July 19, 2000;
(2000)
160159597.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. A. Williams, A. W. Nienhuis, R. G. Hawley, and F. O. Smith
Gene Therapy 2000
Hematology,
January 1, 2000;
2000(1):
376 - 393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Robbins, Q. Lin, J. B. Goodnough, H. Tian, X. Chen, and P. A. Khavari
In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa
PNAS,
April 24, 2001;
98(9):
5193 - 5198.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Emery, E. Yannaki, J. Tubb, and G. Stamatoyannopoulos
A chromatin insulator protects retrovirus vectors from chromosomal position effects
PNAS,
August 1, 2000;
97(16):
9150 - 9155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
